Výsledky vyhledávání - "Tomoko Tokioka"

Comparison of the Angiotensin II Type 1-Receptor Antagonist YM358 and the Angiotensin-Converting Enzyme Inhibitor Enalapril in Rats With Cardiac Volume Overload

Autor: Osamu Inagaki, Isao Yanagisawa, Akira Fujimori, Tomoko Tokioka-Akagi, Masayuki Shibasaki

Publikováno v: Japanese Journal of Pharmacology. 86:79-85

We evaluated the effects of chronic oral administration of an angiotensin II type 1 (AT1)-receptor antagonist YM358 and an angiotensin converting enzyme inhibitor enalapril on hemodynamics and cardiac hypertrophy in rats with volume overload-induced

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dd9fee00cbb44cd55171f623a134d5e
https://doi.org/10.1254/jjp.86.79

Zobrazit plný text záznamu

Effects of YM358, an Angiotensin II Type 1(AT1) Receptor Antagonist, and Enalapril on Blood Pressure and Vasoconstriction in Two Renal Hypertension Models

Autor: Isao Yanagisawa, Yasuko Matsuda-Satoh, Masayuki Shibasaki, Osamu Inagaki, Akira Fujimori, Wataru Uchida, Tomoko Tokioka

Publikováno v: Biological and Pharmaceutical Bulletin. 23:174-181

The effects of the angiotensin II type 1 receptor antagonist YM358 on blood pressure were compared to those of the angiotensin converting enzyme inhibitor enalapril in one-kidney, one-clip renal hypertensive rats (1K1C RHR), two-kidney, one-clip rena

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3039a0a65e81092f1c34fc19a2787c5a
https://doi.org/10.1248/bpb.23.174

Zobrazit plný text záznamu

Effects of angiotensin II type 1 receptor antagonist, YM358, on cardiac hypertrophy and dysfunction after myocardial infarction in rats

Autor: Tomoko Tokioka-Akagi, Isao Yanagisawa, Akira Fujimori, Osamu Inagaki, Masayuki Shibasaki, Yasuko Matsuda-Satoh

Publikováno v: Biologicalpharmaceutical bulletin. 25(7)

This study was undertaken to investigate the effects of an angiotensin II type 1 receptor antagonist, YM358 (2,7-diethyl-5-[[2'(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo [1,5-b] [1,2,4]triazole potassium salt monohydrate), on cardiac hypertr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9142d24ebf49bcad2318cee944fa6595
https://pubmed.ncbi.nlm.nih.gov/12132657

Zobrazit plný text záznamu

Cardiovascular and renal effects of conivaptan hydrochloride (YM087), a vasopressin V1A and V2 receptor antagonist, in dogs with pacing-induced congestive heart failure

Autor: Akihiro Tanaka, Toshiyuki Kusayama, Junko Tsukada, Yuichi Tomura, Atsuo Tahara, Koh-ichi Wada, Yuichi Iizumi, Osamu Inagaki, Kazuo Honda, Wataru Uchida, Takeyuki Yatsu, Tomoko Tokioka

Publikováno v: European journal of pharmacology. 376(3)

The systemic hemodynamic and renal responses to conivaptan hydrochloride (YM087; 4'-(2-methyl-1,4,5,6-tetrahydroimidazo[4,5-d][1]benzoazepine -6-carbonyl)-2-phenylbenzanilide monohydrochloride), a vasopressin V1A and V2 receptor antagonist, were dete

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2ce4b5ec2f136b61c6624b90067ef3af
https://pubmed.ncbi.nlm.nih.gov/10448882

Zobrazit plný text záznamu

Pharmacological profile of YM358, a novel nonpeptide angiotensin AT1 receptor antagonist

Autor: Akira Fujimori, Yasuko Satoh, Toshiyuki Kusayama, Tomoko Tokioka, Masahiro Takanashi, Masayuki Shibasaki, Toshio Okazaki, Isao Yanagisawa, Osamu Inagaki, Wataru Uchida

Publikováno v: European journal of pharmacology. 335(2-3)

The pharmacological profile of YM358, 2,7-diethyl-5-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo[1,5-b][1,2,4]tri azole potassium salt monohydrate, a novel non-peptide angiotensin AT1 receptor antagonist, was studied in vitro and in vivo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fdc4eabf771cfaff35cffdcb28382d36
https://pubmed.ncbi.nlm.nih.gov/9369370

Zobrazit plný text záznamu

Antihypertensive activity of a nonpeptide angiotensin II receptor antagonist, YM358, in rats and dogs

Autor: Masayuki Shibasaki, Akira Fujimori, Yasuko Satoh, Toshiyuki Kusayama, I. Yanagisawa, Osamu Inagaki, Uchida Wataru, Toshio Okazaki, Tomoko Tokioka

Publikováno v: European journal of pharmacology. 335(2-3)

The antihypertensive activity of YM358, 2,7-diethyl-5-[[2-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-5H-pyrazolo-[1,5-b] [1,2,4]triazole potassium salt monohydrate, a new nonpeptide angiotensin II receptor antagonist, was characterized in rats and dogs.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2fdb837818fdbdeddf02632a4de4dcb
https://pubmed.ncbi.nlm.nih.gov/9369371

Zobrazit plný text záznamu

Difference in the vascular renin-angiotensin system in two types of renovascular hypertensive rats

Autor: Toshio Okazaki, Wataru Uchida, Akira Fujimori, Osama Inagaki, Isao Yanagisawa, Toichi Takenaka, Noboru Sato, Tomoko Tokioka, Masayuki Shibasaki

Publikováno v: Japanese Journal of Pharmacology. 67:264

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d085e40c4759efc7bcbb44cd310c2da
https://doi.org/10.1016/s0021-5198(19)47020-0

Zobrazit plný text záznamu

Antihypertensive effects of YM358, a novel angiotensin II receptor antagonist, in rats with one-kidney, one clip hypertension

Autor: Noboru Sato, Toichi Takenaka, Osamu Inagaki, Tomoko Tokioka, Isao Yanagisawa, Toshio Okazaki, Masayuki Shibasaki

Publikováno v: Japanese Journal of Pharmacology. 64:83

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::f542682972cf8e663d672b6685189aaf
https://doi.org/10.1016/s0021-5198(19)49976-9

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání